galantamine and kynurenine

galantamine has been researched along with kynurenine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albuquerque, EX; Bruno, JP; Pellicciari, R; Pereira, EF; Schwarcz, R; Wu, HQ1
Alexander, KS; Bruno, JP; Schwarcz, R; Wu, HQ1
Alexander, KS; Bruno, JP; Pershing, ML; Pocivavsek, A; Schwarcz, R; Wu, HQ1
Darlington, LG; Forrest, CM; Khalil, OS; McNair, K; Pisar, M; Stone, TW1
Aaronson, ST; Davis, W; Koola, MM; Kozak, R; Meissen, JK; Nikiforuk, A; Sawant-Basak, A; Sklar, J1

Trials

1 trial(s) available for galantamine and kynurenine

ArticleYear
Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Schizophrenia research, 2018, Volume: 193

    Topics: Adolescent; Adult; Cognitive Dysfunction; Drug Therapy, Combination; Female; Galantamine; Humans; Kynurenine; Male; Memantine; Middle Aged; Neuropsychological Tests; Nootropic Agents; Retrospective Studies; Schizophrenia; Signal Transduction; Young Adult

2018

Other Studies

4 other study(ies) available for galantamine and kynurenine

ArticleYear
The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Journal of molecular neuroscience : MN, 2010, Volume: 40, Issue:1-2

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; Cholinesterase Inhibitors; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extracellular Fluid; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Microdialysis; Nicotinic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Schizophrenia

2010
Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
    Psychopharmacology, 2012, Volume: 220, Issue:3

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Nootropic Agents; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Nicotinic; Schizophrenia

2012
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Neuroscience, 2013, May-15, Volume: 238

    Topics: Animals; Attention; Brain; Cognition; Female; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Nootropic Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Set, Psychology

2013
Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.
    Neuroscience, 2015, Dec-03, Volume: 310

    Topics: Adjuvants, Pharmaceutic; Animals; Doublecortin Domain Proteins; Doublecortin Protein; Female; Galantamine; Gene Expression Regulation; Gestational Age; Hippocampus; In Vitro Techniques; Kynurenine; Kynurenine 3-Monooxygenase; Long-Term Potentiation; Male; Mice; Mice, Knockout; Microtubule-Associated Proteins; Neuronal Plasticity; Neuropeptides; Nootropic Agents; Pregnancy; Prenatal Exposure Delayed Effects; Probenecid; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Glutamate

2015